Renal cell carcinoma physical examination: Difference between revisions
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) (→HEENT) |
||
Line 19: | Line 19: | ||
===HEENT=== | ===HEENT=== | ||
*Facial [[flushing]] may be present. | |||
===Neck=== | ===Neck=== |
Revision as of 17:54, 26 July 2018
Renal cell carcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Renal cell carcinoma physical examination On the Web |
American Roentgen Ray Society Images of Renal cell carcinoma physical examination |
Risk calculators and risk factors for Renal cell carcinoma physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Common physical examination findings of renal cell carcinoma include low body mass index, high blood pressure, palpation of abdominal mass, auscultation of abdominal bruit, varicocele, muscle atrophy, skin pallor, facial flushing, and supraclavicular lymphadenopathy.
Physical Examination
Physical examination of patients with [disease name] is usually remarkable for pallor, low body mass index, high blood pressure, palpation of abdominal mass and auscultation of abdominal bruit.[1]
Appearance of the Patient
- Patients with renal cell carcinoma usually appear cachexectic.
Vital Signs
- Hyperthermia may be present.
- High low blood pressure with normal pulse pressure
Skin
HEENT
- Facial flushing may be present.
Neck
- Supraclavicular lymphadenopathy
Lungs
- Pulmonary examination of patients with renal cell carcinoma is usually normal.
Heart
- Cardiovascular examination of patients with renal cell carcinoma is usually normal.
Abdomen
- Palpation of abdominal mass
- Auscultation of abdominal bruit
Back
- Back examination of patients with renal cell carcinoma is usually normal.
Genitourinary
- Varicocele may be present.
Neuromuscular
- Neuromuscular examination of patients with renal cell carcinoma is usually normal.
Extremities
- Muscle atrophy may be present
References
- ↑ Cairns P (2010). "Renal cell carcinoma". Cancer Biomark. 9 (1–6): 461–73. doi:10.3233/CBM-2011-0176. PMC 3308682. PMID 22112490.